4559:TYO
Zeria Pharmaceutical Co Ltd
1 913,00 JP¥
arrow_downward
-0,05%(-1,00) 1D
7-окт., 09:17:05 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
1 910 JP¥
High
1 917 JP¥
Low
1 906 JP¥
Mkt. cap
95,88 млд
Avg. vol.
169,52 миң
Volume
16,20 миң
Dividend
2,56%
Quarterly dividend
12 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,25
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 миң
Open
1 910 JP¥
High
1 917 JP¥
Low
1 906 JP¥
Mkt. cap
95,88 млд
Avg. vol.
169,52 миң
Volume
16,20 миң
Dividend
2,56%
Quarterly dividend
12 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,25
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 миң
News stories
From web sources and news partners
Simply Wall Street
·
59 мүнөт мурун
GeneDx Holdings (WGS) Launches Easy Order As Pediatric Testing Narrative Shapes Valuation
Investing.com
·
16 мүнөт мурун
U.S. stock futures steady after tech rally lifts S&P 500, Nasdaq to records
24/7 Wall St.
·
29 мүнөт мурун
SCHD Beat the S&P 500 Over One Year and Trailed It Over Five. Here Is What the Yield Bought
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 миң
Founded1955-ж., 22-дек.
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp